Immunoassay Analyzers Market Share, Growth & Forecast [2031]
Immunoassay Analyzers Market Share, Growth & Forecast [2031]
Segments - Immunoassay Analyzers Market by Application (Oncology, Cardiology, Allergy Testing, AIDS, Endocrinology, Infectious Disease Testing, Therapeutic Drug Monitoring, Autoimmune Disease, and Others), Product Type (Enzyme-Linked Immunoassay, Consumables, Accessories, Chemiluminescence Immunoassay, Immunofluorescence Analyzers, and Radioimmunoassay), End-user (Diagnostic Laboratories, Research Institutes, Hospitals, and Others), and Region (Asia Pacific, North America, Latin America, Europe, and Middle East & Africa) - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast 2022 – 2030
Upcoming
| Report ID :HC-4827
| 4.9 Rating
| 73 Reviews
| 211 Pages
| Format :
Report Description
The global immunoassay analyzers market size was around USD 10.14 billion in 2021 and is estimated to reach USD 28.18 billion by 2030, expanding at a CAGR of 15.7% during the forecast period, 2022–2030. The market growth is attributed to the increasing demand for immunoassay in order to detect and diagnose bacteria and virus-based infections and diseases.
Immunoassay analyzers are medical devices that are used for the immunoassay test which aids in the detection of a specific protein in a particular blood sample. This equipment determines the presence or quantity of proteins in analyte samples using the principles of antigen-antibody binding. Immunoassays play a vital role in treatment planning and disease diagnosis. Hospitals and clinical laboratories employ a clinical immunoassay analyzer for allergy testing, drug monitoring, and the diagnosis of infectious diseases.
Samples that are collected from individuals undergo various immunoassay analyzer tests including enzyme, fluorescence polarization, ion capture, and chemiluminescence. Antibodies are used in immunoassay testing to find minute biological components in blood and other body fluids. The process is based on the idea that specific antigens attach to specific antibodies, inducing an immunological response.
Immunoassay automation offers many advantages to labs, including the potential to easily extend their product line, boost productivity and profitability, and enhance analytical performance. However, manually carrying out immunoassay requires a lot of work and relies on techniques that can differ from user to user.
COVID-19 Impact
The research report finds that the COVID-19 pandemic opened up various growth opportunities for the global immunoassay analyzers market. Immunoassay analyzers are regarded as cornerstones in the management of pandemics due to the increasing demand for diagnostic solutions. Confirmatory testing enables quick virus diagnosis and stops future transmission by isolating individuals.
In order to combat the COVID-19 pandemic, mass testing has gained attention. European countries such as Russia, France, U.K., Italy, Spain, and Germany have reported a maximum number of COVID-19 cases as government organizations conducted mass COVID-19 testing. Therefore, government organizations undertaking a series of initiatives to increase the number of analyzers, instruments, and testing kits in order to boost the testing rate in their countries.
Immunoassay Analyzers Market Dynamics
The market research report presents a complete overview by providing a detailed analysis of the current market trends, existing drivers, growth opportunities, and emerging challenges. The global immunoassay analyzers market report offers up-to-date information about factors that can shape the market outcome or overall performance during the forecast period, 2022 to 2030.
Major Drivers
Increasing incidence of chronic and infectious diseases
The increasing incidence of chronic and infectious diseases is anticipated to drive market growth in the coming years. The growing requirement to control and reduce the incidence of serious diseases and increasing demand for immunoassays to diagnose and detect infections caused by various microorganisms are key factors that contribute to the growth of the immunoassay analyzers market.
Current Restraints
Low detection limit of existing technology
The low detection limit of existing technology is expected to hamper the market during the forecast period. Immunoassay is not adapted to a multianalyte method as each antibody binds to a single analyte or class of analyte. Antibodies show cross-reactivity, they bind to structural analogs of the analyte of interest.
Other issues involve the unsuitability for high-throughput screening analysis, the need for high sample volumes for detection, complex workflows, and reagent instability. Moreover, immunoassay is associated with false negatives during the early stage of the infections. The slightly symptomatic to asymptomatic individuals with low titer of antibodies in response to the coronavirus infections struggle with this incorrect sensitivity.
Market Opportunities
Rising demand for automated and portable immunoassay systems
The rising demand for automated and portable immunoassay systems is projected to create lucrative opportunities for the key market players. Automation provides high efficacy, immense sampling volume, large storage, rapid processing, and scale-up flexibility needed for diagnosis and management. Furthermore, portable immunoassay systems feature disposable capillary columns as the reaction sites and use real-time calibration for improved accuracy. It is an automated low-cost immunoassay system and designed, developed, and evaluated with several protein analytes.
Scope of Immunoassay Analyzers Market Report
The global immunoassay analyzers market research report includes an assessment of the market trends, segments, and regional markets. Overview and dynamics have also been included in the report.
|
Attributes |
Details |
|
Report Title |
Immunoassay Analyzers Market - Global Industry Analysis, Growth, Share, Size, Trends, and Forecast |
|
Base Year |
2021 |
|
Historic Data |
2019–2020 |
|
Forecast Period |
2022–2030 |
|
Segmentation |
Application (Oncology, Cardiology, Allergy Testing, AIDS, Endocrinology, Infectious Disease Testing, Therapeutic Drug Monitoring, Autoimmune Disease, and Others), Product Type (Enzyme-Linked Immunoassay, Consumables, Accessories, Chemiluminescence Immunoassay, Immunofluorescence Analyzers, and Radioimmunoassay), and End-user (Diagnostic Laboratories, Research Institutes, Hospitals, and Others) |
|
Regional Scope |
Asia Pacific, North America, Latin America, Europe, and Middle East & Africa |
|
Report Coverage |
Company Share, Market Analysis and Size, Competitive Landscape, Growth Factors, Market Trends, and Revenue Forecast |
|
Key Players Covered in the Report |
Immunodiagnostic Systems; Merck KGaA; Olympus Corporation; Nova Century Scientific; Inc.; Luminex Corporation; DiaSorin S.p.A.; Bio-Rad Laboratories; Inc.; Randox Laboratories Ltd.; Tecan Trading AG; Siemens; Thermo Fisher Scientific; Inc.; F. Hoffmann-La Roche Ltd.; Abbott; BD; Beckman Coulter; Inc.; Ortho Clinical Diagnostics; bioMérieux SA; Biokit S.A; The Binding Site Group Ltd.; and Quidel Corporation |
Immunoassay Analyzers Market Segment Insights
Infectious disease testing segment to expand at a considerable CAGR
On the basis of application, the global immunoassay analyzers market is segmented into oncology, cardiology, allergy testing, aids, endocrinology, infectious disease testing, therapeutic drug monitoring, autoimmune disease, and others. The infectious disease testing segment is projected to expand at a considerable CAGR during the forecast period, due to rising infectious diseases, unhealthy sanitary habits, and cross-country migrations. The demand for diagnosis of infectious diseases is increased, as the genetic mutations in bacteria and viruses result in drug resistance.
Moreover, government initiatives and the high prevalence of infectious diseases result in the adoption of diagnostic measures. The oncology segment is anticipated to account for a major market share during the forecast period, owing to the incidence and prevalence of cancer cases taking place globally. Immunoassay analyzers are widely used for early diagnosis and monitoring of cancer. The oncology segment is expected to grow with a CAGR of over 11% during the forecast period.
Enzyme-linked immunoassay segment to hold a significant market share
Based on product type, the market is divided into enzyme-linked immunoassay, consumables, accessories, chemiluminescence immunoassay, immunofluorescence analyzers, and radioimmunoassay. The enzyme-linked immunoassay segment is expected to hold a significant share of the market in the coming years, due to its wide application in the number of diagnostic tests and high sensitivity.
Moreover, automated screening processes and the introduction of high-throughput techniques increase the demand for chemiluminescence assays. Thus, the chemiluminescence immunoassay segment is anticipated to grow at a significant growth rate.
Hospitals segment to expand at a substantial CAGR
On the basis of end-user, the global immunoassay analyzers market is segregated into diagnostic laboratories, research institutes, hospitals, and others. The hospitals segment is anticipated to expand at a substantial CAGR during the forecast period, owing to rising healthcare infrastructure and investments. The rising demand for new and improved drugs has increased the number of testing procedures.
This, in turn, increases the demand for assays, that are used to measure and monitor different types of diseases. Moreover, the research institutes segment is expected to hold a significant share of the market, due to rising demand for advanced diagnostic devices.
North America to dominate the market
In terms of regions, the global market is classified as Asia Pacific, North America, Latin America, Europe, and Middle East & Africa. North America is expected to dominate the market during the forecast period, owing to the high adoption rate of technologically advanced products in the region. North America dominates all other regions with a revenue share of 38.0% closely followed by Europe. Additionally, the presence of major players in the region is generating revenue for the United States.
The market in Asia Pacific is anticipated to expand at a rapid pace during the forecast period, owing to the growing medical tourism industry in the region. Production facilities of major pharmaceutical manufacturers are moving to the Asia Pacific region, due to the advanced manufacturing infrastructure and availability of skilled labor at reasonable prices. Japan is one of the top countries for higher usage of immunoassay testing for a range of purposes and strong technological advancements. Asia Pacific region is projected to witness fast growth at a CAGR of 7% during the forecast period.
Segments
The global immunoassay analyzers market has been segmented on the basis of
Application
- Oncology
- Cardiology
- Allergy Testing
- AIDS
- Endocrinology
- Infectious Disease Testing
- Therapeutic Drug Monitoring
- Autoimmune Disease
- Others
Product Type
- Enzyme-Linked Immunoassay
- Consumables
- Accessories
- Chemiluminescence Immunoassay
- Immunofluorescence Analyzers
- Radioimmunoassay
End-user
- Diagnostic Laboratories
- Research Institutes
- Hospitals
- Others
Region
- Asia Pacific
- North America
- Latin America
- Europe
- Middle East & Africa
Key Players
- Immunodiagnostic Systems
- Merck KGaA
- Olympus Corporation
- Nova Century Scientific Inc.
- Luminex Corporation
- DiaSorin S.p.A.
- Bio-Rad Laboratories Inc.
- Randox Laboratories Ltd.
- Tecan Trading AG
- Siemens
- Thermo Fisher Scientific Inc.
- F. Hoffmann-La Roche Ltd.
- Abbott
- BD
- Beckman Coulter Inc.
- Ortho Clinical Diagnostics
- bioMérieux SA
- Biokit S.A
- The Binding Site Group Ltd.
- Quidel Corporation
Competitive Landscape
Key players competing in the global immunoassay analyzers market are Immunodiagnostic Systems; Merck KGaA; Olympus Corporation; Nova Century Scientific; Inc.; Luminex Corporation; DiaSorin S.p.A.; Bio-Rad Laboratories; Inc.; Randox Laboratories Ltd.; Tecan Trading AG; Siemens; Thermo Fisher Scientific; Inc.; F. Hoffmann-La Roche Ltd.; Abbott; BD; Beckman Coulter; Inc.; Ortho Clinical Diagnostics; bioMérieux SA; Biokit S.A; The Binding Site Group Ltd.; and Quidel Corporation.
Key players are actively engaged in R&D programs and aim at the expansion of manufacturing units to expand their consumer base and increase their product portfolio. In September 2021, Thermo Fisher Scientific, Inc. launched its fully automated analyzers.
These analyzers are named Thermo Scientific Gallery Enzyme Master and Thermo Scientific Gallery Plus Enzyme Master which are specifically designed for enzyme assay applications. In addition, In February 2021, F.Hoffman-La Roche launched the SARS-CoV-2 Rapid Antigen Test Nasal with patient self-collection.
Frequently Asked Questions
Key players competing in the global immunoassay analyzers market are Immunodiagnostic Systems; Merck KGaA; Olympus Corporation; Nova Century Scientific; Inc.; Luminex Corporation; DiaSorin S.p.A.; Bio-Rad Laboratories; Inc.; Randox Laboratories Ltd.; Tecan Trading AG; Siemens; Thermo Fisher Scientific; Inc.; F. Hoffmann-La Roche Ltd.; Abbott; BD; Beckman Coulter; Inc.; Ortho Clinical Diagnostics; bioMérieux SA; Biokit S.A; The Binding Site Group Ltd.; and Quidel Corporation.
North America is expected to dominate the market during the forecast period.
The global immunoassay analyzers market is expanding at a Compound Annual Growth Rate (CAGR) of 15.7% during the forecast period, 2022–2030.
The increasing incidence of chronic and infectious diseases is anticipated to drive market growth in the coming years.
The global immunoassay analyzers market size was around USD 10.14 billion in 2021 and is estimated to reach USD 28.18 billion by 2030.
Table Of Content
1. Executive Summary2. Assumptions and Acronyms Used
3. Research Methodology
4. Immunoassay Analyzers Market Overview
4.1. Introduction
4.1.1. Market Taxonomy
4.1.2. Market Definition
4.2. Macro-Economic Factors
4.2.1. Industry Outlook
4.3. Immunoassay Analyzers Market Dynamics
4.3.1. Market Drivers
4.3.2. Market Restraints
4.3.3. Opportunity
4.3.4. Market Trends
4.4. Immunoassay Analyzers Market - Supply Chain
4.5. Global Immunoassay Analyzers Market Forecast
4.5.1. Immunoassay Analyzers Market Size (US$ Mn) and Y-o-Y Growth
4.5.2. Immunoassay Analyzers Market Size (000’ Units) and Y-o-Y Growth
4.5.3. Immunoassay Analyzers Market Absolute $ Opportunity
5. Global Immunoassay Analyzers Market Analysis and Forecast by Applications
5.1. Market Trends
5.2. Introduction
5.2.1. Basis Point Share (BPS) Analysis by Applications
5.2.2. Y-o-Y Growth Projections by Applications
5.3. Immunoassay Analyzers Market Size and Volume Forecast by Applications
5.3.1. Oncology
5.3.2. Cardiology
5.3.3. Allergy Testing
5.3.4. AIDS
5.3.5. Endocrinology
5.3.6. Infectious Disease Testing
5.3.7. Therapeutic Drug Monitoring
5.3.8. Autoimmune Disease
5.4. Absolute $ Opportunity Assessment by Applications
5.5. Market Attractiveness/Growth Potential Analysis by Applications
6. Global Immunoassay Analyzers Market Analysis and Forecast by End Users
6.1. Market Trends
6.2. Introduction
6.2.1. Basis Point Share (BPS) Analysis by End Users
6.2.2. Y-o-Y Growth Projections by End Users
6.3. Immunoassay Analyzers Market Size and Volume Forecast by End Users
6.3.1. Diagnostic Laboratories
6.3.2. Research Institutes
6.3.3. Hospitals
6.3.4. Others
6.4. Absolute $ Opportunity Assessment by End Users
6.5. Market Attractiveness/Growth Potential Analysis by End Users
7. Global Immunoassay Analyzers Market Analysis and Forecast by Region
7.1. Market Trends
7.2. Introduction
7.2.1. Basis Point Share (BPS) Analysis by Region
7.2.2. Y-o-Y Growth Projections by Region
7.3. Immunoassay Analyzers Market Size and Volume Forecast by Region
7.3.1. North America
7.3.2. Latin America
7.3.3. Europe
7.3.4. Asia Pacific
7.3.5. Middle East and Africa (MEA)
7.4. Absolute $ Opportunity Assessment by Region
7.5. Market Attractiveness/Growth Potential Analysis by Region
7.6. Global Immunoassay Analyzers Demand Share Forecast, 2019-2026
8. North America Immunoassay Analyzers Market Analysis and Forecast
8.1. Introduction
8.1.1. Basis Point Share (BPS) Analysis by Country
8.1.2. Y-o-Y Growth Projections by Country
8.2. North America Immunoassay Analyzers Market Size and Volume Forecast by Country
8.2.1. U.S.
8.2.2. Canada
8.3. Absolute $ Opportunity Assessment by Country
8.4. North America Immunoassay Analyzers Market Size and Volume Forecast by Applications
8.4.1. Oncology
8.4.2. Cardiology
8.4.3. Allergy Testing
8.4.4. AIDS
8.4.5. Endocrinology
8.4.6. Infectious Disease Testing
8.4.7. Therapeutic Drug Monitoring
8.4.8. Autoimmune Disease
8.5. Basis Point Share (BPS) Analysis by Applications
8.6. Y-o-Y Growth Projections by Applications
8.7. North America Immunoassay Analyzers Market Size and Volume Forecast by End Users
8.7.1. Diagnostic Laboratories
8.7.2. Research Institutes
8.7.3. Hospitals
8.7.4. Others
8.8. Basis Point Share (BPS) Analysis by End Users
8.9. Y-o-Y Growth Projections by End Users
8.10. Market Attractiveness/Growth Potential Analysis
8.10.1. By Country
8.10.2. By Product Type
8.10.3. By Application
8.11. North America Immunoassay Analyzers Demand Share Forecast, 2019-2026
9. Latin America Immunoassay Analyzers Market Analysis and Forecast
9.1. Introduction
9.1.1. Basis Point Share (BPS) Analysis by Country
9.1.2. Y-o-Y Growth Projections by Country
9.1.3. Latin America Average Pricing Analysis
9.2. Latin America Immunoassay Analyzers Market Size and Volume Forecast by Country
9.2.1. Brazil
9.2.2. Mexico
9.2.3. Rest of Latin America
9.3. Absolute $ Opportunity Assessment by Country
9.4. Latin America Immunoassay Analyzers Market Size and Volume Forecast by Applications
9.4.1. Oncology
9.4.2. Cardiology
9.4.3. Allergy Testing
9.4.4. AIDS
9.4.5. Endocrinology
9.4.6. Infectious Disease Testing
9.4.7. Therapeutic Drug Monitoring
9.4.8. Autoimmune Disease
9.5. Basis Point Share (BPS) Analysis by Applications
9.6. Y-o-Y Growth Projections by Applications
9.7. Latin America Immunoassay Analyzers Market Size and Volume Forecast by End Users
9.7.1. Diagnostic Laboratories
9.7.2. Research Institutes
9.7.3. Hospitals
9.7.4. Others
9.8. Basis Point Share (BPS) Analysis by End Users
9.9. Y-o-Y Growth Projections by End Users
9.10. Market Attractiveness/Growth Potential Analysis
9.10.1. By Country
9.10.2. By Product Type
9.10.3. By Application
9.11. Latin America Immunoassay Analyzers Demand Share Forecast, 2019-2026
10. Europe Immunoassay Analyzers Market Analysis and Forecast
10.1. Introduction
10.1.1. Basis Point Share (BPS) Analysis by Country
10.1.2. Y-o-Y Growth Projections by Country
10.1.3. Europe Average Pricing Analysis
10.2. Europe Immunoassay Analyzers Market Size and Volume Forecast by Country
10.2.1. Germany
10.2.2. France
10.2.3. Italy
10.2.4. U.K.
10.2.5. Spain
10.2.6. Russia
10.2.7. Rest of Europe
10.3. Absolute $ Opportunity Assessment by Country
10.4. Europe Immunoassay Analyzers Market Size and Volume Forecast by Applications
10.4.1. Oncology
10.4.2. Cardiology
10.4.3. Allergy Testing
10.4.4. AIDS
10.4.5. Endocrinology
10.4.6. Infectious Disease Testing
10.4.7. Therapeutic Drug Monitoring
10.4.8. Autoimmune Disease
10.5. Basis Point Share (BPS) Analysis by Applications
10.6. Y-o-Y Growth Projections by Applications
10.7. Europe Immunoassay Analyzers Market Size and Volume Forecast by End Users
10.7.1. Diagnostic Laboratories
10.7.2. Research Institutes
10.7.3. Hospitals
10.7.4. Others
10.8. Basis Point Share (BPS) Analysis by End Users
10.9. Y-o-Y Growth Projections by End Users
10.10. Market Attractiveness/Growth Potential Analysis
10.10.1. By Country
10.10.2. By Product Type
10.10.3. By Application
10.11. Europe Immunoassay Analyzers Demand Share Forecast, 2019-2026
11. Asia Pacific Immunoassay Analyzers Market Analysis and Forecast
11.1. Introduction
11.1.1. Basis Point Share (BPS) Analysis by Country
11.1.2. Y-o-Y Growth Projections by Country
11.1.3. Asia Pacific Average Pricing Analysis
11.2. Asia Pacific Immunoassay Analyzers Market Size and Volume Forecast by Country
11.2.1. China
11.2.2. Japan
11.2.3. South Korea
11.2.4. India
11.2.5. Australia
11.2.6. Rest of Asia Pacific (APAC)
11.3. Absolute $ Opportunity Assessment by Country
11.4. Asia Pacific Immunoassay Analyzers Market Size and Volume Forecast by Applications
11.4.1. Oncology
11.4.2. Cardiology
11.4.3. Allergy Testing
11.4.4. AIDS
11.4.5. Endocrinology
11.4.6. Infectious Disease Testing
11.4.7. Therapeutic Drug Monitoring
11.4.8. Autoimmune Disease
11.5. Basis Point Share (BPS) Analysis by Applications
11.6. Y-o-Y Growth Projections by Applications
11.7. Asia Pacific Immunoassay Analyzers Market Size and Volume Forecast by End Users
11.7.1. Diagnostic Laboratories
11.7.2. Research Institutes
11.7.3. Hospitals
11.7.4. Others
11.8. Basis Point Share (BPS) Analysis by End Users
11.9. Y-o-Y Growth Projections by End Users
11.10. Market Attractiveness/Growth Potential Analysis
11.10.1. By Country
11.10.2. By Product Type
11.10.3. By Application
11.11. Asia Pacific Immunoassay Analyzers Demand Share Forecast, 2019-2026
12. Middle East & Africa Immunoassay Analyzers Market Analysis and Forecast
12.1. Introduction
12.1.1. Basis Point Share (BPS) Analysis by Country
12.1.2. Y-o-Y Growth Projections by Country
12.1.3. Middle East & Africa Average Pricing Analysis
12.2. Middle East & Africa Immunoassay Analyzers Market Size and Volume Forecast by Country
12.2.1. Saudi Arabia
12.2.2. South Africa
12.2.3. UAE
12.2.4. Rest of Middle East & Africa (MEA)
12.3. Absolute $ Opportunity Assessment by Country
12.4. Middle East & Africa Immunoassay Analyzers Market Size and Volume Forecast by Applications
12.4.1. Oncology
12.4.2. Cardiology
12.4.3. Allergy Testing
12.4.4. AIDS
12.4.5. Endocrinology
12.4.6. Infectious Disease Testing
12.4.7. Therapeutic Drug Monitoring
12.4.8. Autoimmune Disease
12.5. Basis Point Share (BPS) Analysis by Applications
12.6. Y-o-Y Growth Projections by Applications
12.7. Middle East & Africa Immunoassay Analyzers Market Size and Volume Forecast by End Users
12.7.1. Diagnostic Laboratories
12.7.2. Research Institutes
12.7.3. Hospitals
12.7.4. Others
12.8. Basis Point Share (BPS) Analysis by End Users
12.9. Y-o-Y Growth Projections by End Users
12.10. Market Attractiveness/Growth Potential Analysis
12.10.1. By Country
12.10.2. By Product Type
12.10.3. By Application
12.11. Middle East & Africa Immunoassay Analyzers Demand Share Forecast, 2019-2026
13. Competition Landscape
13.1. Global Immunoassay Analyzers Market: Market Share Analysis
13.2. Immunoassay Analyzers Distributors and Customers
13.3. Immunoassay Analyzers Market: Competitive Dashboard
13.4. Company Profiles (Details: Overview, Financials, Developments, Strategy)
13.4.1. Immunodiagnostic Systems
13.4.2. Merck KGaA
13.4.3. Olympus Corporation
13.4.4. Nova Century Scientific Inc.
13.4.5. Luminex Corporation
13.4.6. DiaSorin S.p.A.
13.4.7. Bio-Rad Laboratories Inc.
13.4.8. Randox Laboratories Ltd.
13.4.9. Tecan Trading AG
13.4.10. Siemens
13.4.11. Thermo Fisher Scientific Inc.
13.4.12. F. Hoffmann-La Roche Ltd.
13.4.13. Abbott
13.4.14. BD
13.4.15. Beckman Coulter Inc.
13.4.16. Ortho Clinical Diagnostics
13.4.17. bioMérieux SA
13.4.18. Biokit S.A
13.4.19. The Binding Site Group Ltd.
13.4.20. Quidel Corporation
Methodology
Related Reports
Some other reports from this category!
Our Clients
